Revelation Biosciences Inc. (REVB) is priced at $0.67 after the most recent trading session. At the very opening of the session, the stock price was $0.4806 and reached a high price of $0.516, prior to closing the session it reached the value of $0.49. The stock touched a low price of $0.4806.Recently in News on June 13, 2022, Revelation Biosciences Inc. Announces Completion of Dosing for a Phase 1b CLEAR Clinical Study of REVTx-99b for the Treatment of Allergic Rhinitis. -Data anticipated in Q3 2022-. You can read further details here
Revelation Biosciences Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $11.2900 on 01/05/22, with the lowest value was $0.4036 for the same time period, recorded on 06/01/22.
Revelation Biosciences Inc. (REVB) full year performance was -95.08%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Revelation Biosciences Inc. shares are logging -94.06% during the 52-week period from high price, and 66.29% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.40 and $11.29.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1893518 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Revelation Biosciences Inc. (REVB) recorded performance in the market was -95.17%, having the revenues showcasing -79.13% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 7.94M, as it employees total of 14 workers.
Market experts do have their say about Revelation Biosciences Inc. (REVB)
During the last month, 0 analysts gave the Revelation Biosciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.1153, with a change in the price was noted -1.69. In a similar fashion, Revelation Biosciences Inc. posted a movement of -71.14% for the period of last 100 days, recording 1,793,578 in trading volumes.
Technical breakdown of Revelation Biosciences Inc. (REVB)
Raw Stochastic average of Revelation Biosciences Inc. in the period of last 50 days is set at 25.81%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 72.76%. In the last 20 days, the company’s Stochastic %K was 43.87% and its Stochastic %D was recorded 35.06%.
Bearing in mind the latest performance of Revelation Biosciences Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -95.17%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -95.16%, alongside a downfall of -95.08% for the period of the last 12 months. The shares increased approximately by 9.27% in the 7-day charts and went up by -8.46% in the period of the last 30 days. Common stock shares were lifted by -79.13% during last recorded quarter.